News

PD Neurotechnology® certifies more than 150 Physicians in the usage of PDMonitor®

Published on: 27/05/2022

PD Neurotechnology® certifies more than 150 Physicians in the usage of PDMonitor®
Digital Health Skills
Member News

In December 2021, PD Neurotechnology® has reached the milestone of 150 trained physicians in the usage of PDMonitor®. In 2020-2021, PD Neurotechnology® has successfully organized 6 in person PDMonitor® Induction and Usage training sessions in Athens, Thessaloniki, London, Lund and 4 Webex trainings at the company’s R&D and Production facility in Ioannina, together with more than 10 additional specialty center virtual sessions. 

More than 150 Physicians from Cyprus, France, Germany, Greece, Ireland, Israel, Italy, Russia, Spain, Sweden, Turkey, UK and US as well as Physiotherapists, PD Nurses and PD Researchers attended the 2-4h sessions offered by Professor Konitsiotis and other members of PD Neurotechnology® and were accordingly certified to use PDMonitor® in their daily practice. 

Professor Konitsiotis showed among others a number of interesting case studies and the Physician Tool, a web-based application used by the Physicians to view and download patient reports with a comprehensive and objective assessment of the disease symptoms. It serves as a patient management tool, while at the same time it stores patient data for 10 years, as an Electronic Patient Record. Professor Konitsiotis commented:

“Through these trainings we have the chance to communicate with movement disorders specialists, exchange views and drive together a true paradigm shift in the Parkinson’s Disease management. Demand for these trainings has surpassed our expectations, leading to a new generation of Parkinson’s Disease specialists, digitally savvy, closely linked to their patients.”

You can find the press release here.

Discover more about PD Neurotechnology Ltd:

PD Neurotechnology Ltd.is an awarded, high-tech medical device company, founded in London, UK in 2015, certified with ISO 9001:2015, ISO 27001:2013, ISO 27701:2019 and ISO 13485:2016. Its first product, PDMonitor is a CE marked, Class IIa medical device, a digital, noninvasive, continuous monitoring system and management tool, used by patients with Parkinson’s Disease, which enables an accurate motor symptom evaluation, coupled with information on lifestyle and drug adherence. A web application offers the treating physician a comprehensive and objective view of the patient status and supports the assessment of the disease stage and prompt and optimal modification of the treatment. PDMonitor® is currently marketed in 10 European countries, soon to be available in the US, post FDA clearance.​

NEWS​

Related News

En Bici Sense Edat focuses on emotional wellbeing and active ageing

11 Jun 2025
Bici Sense Edat focuses on emotional wellbeing, active ageing, and the prevention of social isolation and loneliness. Through meaningful, community-ba...

Connected Health Wins Team of the Year at the Irish News Workplace & Employment Awards 2025

10 Jun 2025
This accolade recognises the company’s unwavering commitment to collaboration, innovation, and excellence in team culture within the healthcare sector...

InnoHSupport – Advisory Services to Professionalise and Scale Healthcare Innovation Procurement

9 Jun 2025

Master Class: Healthcare Procurement Of Innovation

9 Jun 2025

Open Innovation: Screening and care of pre-symptomatic autoimmune Type 1 diabetes

9 Jun 2025

Horizon Europe 2025 Health Calls Open – Deadlines on 16 September

9 Jun 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *